162 related articles for article (PubMed ID: 1734938)
21. 6-Alkyl- and 6-arylandrost-4-ene-3,17-diones as aromatase inhibitors. Synthesis and structure-activity relationships.
Numazawa M; Oshibe M
J Med Chem; 1994 Apr; 37(9):1312-9. PubMed ID: 8176709
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and evaluation of 4-substituted-4-androstene-3,17-dione derivatives as aromatase inhibitors.
Abul-Hajj YJ; Liu XP; Hedge M
J Steroid Biochem Mol Biol; 1995 Aug; 54(3-4):111-9. PubMed ID: 7662584
[TBL] [Abstract][Full Text] [Related]
23. 7 alpha-substituted androstenediones as effective in vitro and in vivo inhibitors of aromatase.
Brueggemeier RW; Li PK; Snider CE; Darby MV; Katlic NE
Steroids; 1987; 50(1-3):163-78. PubMed ID: 3504058
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and biochemical evaluation of inhibitors of estrogen biosynthesis.
Brueggemeier RW; Floyd EE; Counsell RE
J Med Chem; 1978 Oct; 21(10):1007-11. PubMed ID: 722711
[TBL] [Abstract][Full Text] [Related]
25. Enzymic aromatization of 6-alkyl-substituted androgens, potent competitive and mechanism-based inhibitors of aromatase.
Numazawa M; Yoshimura A; Oshibe M
Biochem J; 1998 Jan; 329 ( Pt 1)(Pt 1):151-6. PubMed ID: 9405288
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and structure-activity relationships of 6-phenylaliphatic-substituted C19 steroids having a 1,4-diene, 4,6-diene, or 1,4,6-triene structure as aromatase inhibitors.
Numazawa M; Yamaguchi S
Steroids; 1999 Mar; 64(3):187-96. PubMed ID: 10400379
[TBL] [Abstract][Full Text] [Related]
27. Competitive inhibition and suicide inactivation of human placental aromatase by androst-4-ene-3,6-dione derivatives and 3 alpha-methoxyandrost-4-ene-6,17-dione.
Numazawa M; Mutsumi A; Kigawa H
Chem Pharm Bull (Tokyo); 1990 Nov; 38(11):3076-80. PubMed ID: 2085891
[TBL] [Abstract][Full Text] [Related]
28. Further studies on 6-alkylandrost-4-ene-3,17-diones as aromatase inhibitors: elongation of the 6-alkyl chain.
Numazawa M; Oshibe M
Steroids; 1995 Aug; 60(8):506-11. PubMed ID: 8539792
[TBL] [Abstract][Full Text] [Related]
29. Time-dependent inactivation of aromatase by 6-alkylandrosta-1,4-diene-3,17-diones. Effects of length and configuration of 6-alkyl group.
Numazawa M; Oshibe M; Yamaguchi S; Tachibana M
J Med Chem; 1996 Mar; 39(5):1033-8. PubMed ID: 8676338
[TBL] [Abstract][Full Text] [Related]
30. Effects of the aromatase inhibitor 7 alpha-(4'-amino)phenylthio-4-androstene-3,17-dione in MCF-7 human mammary carcinoma cell culture.
Brueggemeier RW; Katlic NE
Cancer Res; 1987 Sep; 47(17):4548-51. PubMed ID: 3621153
[TBL] [Abstract][Full Text] [Related]
31. Covalent modification of aromatase by a radiolabeled irreversible inhibitor.
Snider CE; Brueggemeier RW
J Steroid Biochem; 1985 Mar; 22(3):325-30. PubMed ID: 3990283
[TBL] [Abstract][Full Text] [Related]
32. 1-Methyl-1,4-androstadiene-3,17-dione (SH 489): characterization of an irreversible inhibitor of estrogen biosynthesis.
Henderson D; Norbisrath G; Kerb U
J Steroid Biochem; 1986 Jan; 24(1):303-6. PubMed ID: 3754599
[TBL] [Abstract][Full Text] [Related]
33. A new hypothesis based on suicide substrate inhibitor studies for the mechanism of action of aromatase.
Covey DF; Hood WF
Cancer Res; 1982 Aug; 42(8 Suppl):3327s-3333s. PubMed ID: 7083195
[TBL] [Abstract][Full Text] [Related]
34. 6-Alkylandrosta-4,6-diene-3,17-diones and their 1,4,6-triene analogs as aromatase inhibitors. Structure-activity relationships.
Numazawa M; Oshibe M; Yamaguchi S
Steroids; 1997; 62(8-9):595-602. PubMed ID: 9292934
[TBL] [Abstract][Full Text] [Related]
35. Aromatase inhibition by 4 beta,5 beta-epoxides of 16 alpha-hydroxyandrostenedione and its 19-oxygenated analogs, potential precursors of estriol production in the feto-placental unit.
Numazawa M; Yoshimura A; Watari Y; Matsuzaki H
Biol Pharm Bull; 2002 Dec; 25(12):1566-9. PubMed ID: 12499641
[TBL] [Abstract][Full Text] [Related]
36. Inhibition study of human placental aromatase with 3-deoxy- and 6-oxo-steroids using [1 beta-3H]16 alpha-hydroxyandrostenedione as a substrate: a comparison to that using [1 beta-3H]androstenedione.
Numazawa M; Mutsumi A
J Steroid Biochem Mol Biol; 1993 Feb; 44(2):199-201. PubMed ID: 8439524
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of 6,7-aziridinyl steroids and related compounds as inhibitors of aromatase (P-450arom).
Njar VC; Grün G; Hartmann RW
J Enzyme Inhib; 1995; 9(3):195-202. PubMed ID: 8847599
[TBL] [Abstract][Full Text] [Related]
38. 6 beta-Propynyl-substituted steroids: mechanism-based enzyme-activated irreversible inhibitors of aromatase.
Akkani A; Paterlini G; Gleason WB; Ojala WH; Abul-Hajj YJ
J Med Chem; 1997 Sep; 40(20):3263-70. PubMed ID: 9379446
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of human placental aromatase in a perfusion model. Comparison with kinetic, cell-free experiments.
Klein H; Bartsch W; Niemand A; Stürenburg HJ; Voigt KD
J Steroid Biochem; 1988 Feb; 29(2):161-9. PubMed ID: 3347056
[TBL] [Abstract][Full Text] [Related]
40. Studies directed toward a mechanistic evaluation of aromatase inhibition by androst-5-ene-7,17-dione. Time-dependent inactivation by the 19-nor and 5 beta, 6 beta-epoxy derivatives.
Numazawa M; Tachibana M
Steroids; 1997 Jul; 62(7):516-22. PubMed ID: 9253790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
